High impact
Mammography (CPB 0584, reviewed 2026-09-10)
Aetna·Identified Oct 5, 2026
Aetna updated its mammography medical policy (CPB 0584) to clarify coverage criteria for screening and diagnostic mammography across multiple patient populations, including new explicit coverage for transfeminine persons aged 40+ with 5+ years hormone use, BRCA-positive men, and high-risk women under 40. The policy also designates artificial intelligence-based mammography, contrast-enhanced mammography (except for high-risk patients with MRI contraindications), and low-dose CT combined mammography as experimental/investigational.